Sniderman AD - Search Results

1

Quantifying Importance of Major Risk Factors for Coronary Heart Disease.

Pencina MJ, Navar AM, Wojdyla D, Sanchez RJ, Khan I, Elassal J, D'Agostino RB Sr, Peterson ED, Sniderman AD. Pencina MJ, et al. Among authors: sniderman ad. Circulation. 2019 Mar 26;139(13):1603-1611. doi: 10.1161/CIRCULATIONAHA.117.031855. Circulation. 2019. PMID: 30586759 Free PMC article.

2

Prognosis in patients with low left ventricular ejection fraction after myocardial infarction. Importance of exercise capacity.

Pilote L, Silberberg J, Lisbona R, Sniderman A. Pilote L, et al. Circulation. 1989 Dec;80(6):1636-41. doi: 10.1161/01.cir.80.6.1636. Circulation. 1989. PMID: 2598426

3

Dyslipoproteinemias after heart and heart-lung transplantation: potential relation to accelerated graft arteriosclerosis.

Bilodeau M, Fitchett DH, Guerraty A, Sniderman AD. Bilodeau M, et al. Among authors: sniderman ad. J Heart Transplant. 1989 Nov-Dec;8(6):454-9. J Heart Transplant. 1989. PMID: 2614546

4

Apolipoprotein B and apolipoprotein AI as predictors of coronary artery disease.

Sniderman AD. Sniderman AD. Can J Cardiol. 1988 Jul;4 Suppl A:24A-30A. Can J Cardiol. 1988. PMID: 3141025 Review.

5

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk.

Sniderman AD, St-Pierre AC, Cantin B, Dagenais GR, Després JP, Lamarche B. Sniderman AD, et al. Am J Cardiol. 2003 May 15;91(10):1173-7. doi: 10.1016/s0002-9149(03)00262-5. Am J Cardiol. 2003. PMID: 12745098

6

Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).

Williams K, Sniderman AD, Sattar N, D'Agostino R Jr, Wagenknecht LE, Haffner SM. Williams K, et al. Among authors: sniderman ad. Circulation. 2003 Nov 11;108(19):2312-6. doi: 10.1161/01.CIR.0000097113.11419.9E. Epub 2003 Oct 27. Circulation. 2003. PMID: 14581403

7

Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity.

Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lespérance J, Lévesque S, Varga S. Solymoss BC, et al. Am J Cardiol. 2004 Jan 15;93(2):159-64. doi: 10.1016/j.amjcard.2003.09.032. Am J Cardiol. 2004. PMID: 14715340

8

Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.

Sattar N, Williams K, Sniderman AD, D'Agostino R Jr, Haffner SM. Sattar N, et al. Among authors: sniderman ad. Circulation. 2004 Oct 26;110(17):2687-93. doi: 10.1161/01.CIR.0000145660.60487.94. Epub 2004 Oct 18. Circulation. 2004. PMID: 15492304

9

The strengths and limitations of the apoB/apoA-I ratio to predict the risk of vascular disease: a Hegelian analysis.

Sniderman AD, Kiss RS. Sniderman AD, et al. Curr Atheroscler Rep. 2007 Oct;9(4):261-5. doi: 10.1007/s11883-007-0031-6. Curr Atheroscler Rep. 2007. PMID: 18173952 Review.

10

Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?

Sniderman A, McQueen M, Contois J, Williams K, Furberg CD. Sniderman A, et al. J Clin Lipidol. 2010 May-Jun;4(3):152-5. doi: 10.1016/j.jacl.2010.03.005. Epub 2010 Mar 18. J Clin Lipidol. 2010. PMID: 21122647 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page